The immunopathogenesis of HIV infection (Q38366893)

2 September 2017

1 reference

title

The immunopathogenesis of HIV infection (English)

1 reference

2 September 2017

0 references

2

Fauci AS

1 reference

2 September 2017

Rosenberg ZF

1

1 reference

2 September 2017

1 January 1989

1 reference

2 September 2017

Advances in Immunology

1 reference

2 September 2017

47

1 reference

2 September 2017

377-431

1 reference

Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cellular immune response to viral peptides in patients exposed to HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular cloning of lymphadenopathy-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

New human and simian HIV-related retroviruses possess functional transactivator (tat) gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Reduced Langerhans’ Cell Ia Antigen and ATPase Activity in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Immunopathogenesis of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The role of cachectin/TNF in endotoxic shock and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nonrandom distribution of antibodies to the TRS protein of human immunodeficiency virus in infected people with different clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Biologic features of HIV-1 that correlate with virulence in the host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular cloning and polymorphism of the human immune deficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of a new human retrovirus from West African patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification of a protein encoded by the vpu gene of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Serum suppression of lymphocyte activation in vitro in acquired immunodeficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Epidemiology of HIV infection and AIDS in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Histopathology of bone marrow in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Animal models for acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Establishment of human glial cell lines chronically infected with the human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Suppression of in vitro haematopoiesis following human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Interaction between CD4 and class II MHC molecules mediates cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prognostic value of Langerhans cells in the epidermis of HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Interleukin 1 activity in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The trans-activator gene of HTLV-III is essential for virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The sor gene of HIV-1 is required for efficient virus transmission in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Biologically diverse molecular variants within a single HIV-1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The human immunodeficiency virus type 2 (HIV-2) contains a novel gene encoding a 16 kD protein associated with mature virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Central nervous system involvement in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The T-cell accessory molecule CD4 recognizes a monomorphic determinant on isolated Ia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Serological characterization of HTLV-III infection in AIDS and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of serum neutralization response to the human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Deficient autologous mixed lymphocyte reaction in Kaposi's sarcoma associated with deficiency of Leu-3+ responder T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus-associated changes in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Envelope sequences of two new United States HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genome organization and transactivation of the human immunodeficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular cloning and characterization of the HTLV-III virus associated with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Tumor promoter, TPA, enhances replication of HTLV-III/LAV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody to lymphadenopathy-associated virus in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infection of monocyte/macrophages by human T lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Pathogenesis of infection with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro responses to Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The neurobiology of human immunodeficiency virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Lymphotoxin is an important T cell-derived growth factor for human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isotypic restriction of the antibody response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV infection: facts and hypotheses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Expression of the art/trs protein of HIV and study of its role in viral envelope synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

High levels of heterodisperse RNAs accumulate in T cells infected with human immunodeficiency virus and in normal thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

West African HIV-2-related human retrovirus with attenuated cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Lymphocyte activation by HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cytokines alter production of HIV-1 from primary mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Functional interaction and partial homology between human immunodeficiency virus and neuroleukin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Development of disease and virus recovery in transgenic mice containing HIV proviral DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The natural history of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Effect of neuropeptides on production of inflammatory cytokines by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular cloning of AIDS-associated retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV infection does not require endocytosis of its receptor, CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infection of B lymphocytes by the human immunodeficiency virus and their susceptibility to cytotoxic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The international epidemiology of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Enhancement of human immunodeficiency virus production by natural lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Transfer of a functional human immune system to mice with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infection of the SCID-hu mouse by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV and HCMV coinfect brain cells in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Patterns of antibody response in individuals infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Infection of the retina by human immunodeficiency virus type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus (HIV) infection of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular organization of the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Lymphoproliferative responses to human immunodeficiency virus antigen in asymptomatic intravenous drug abusers and in patients with lymphadenopathy or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The differentiation and function of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Separation of functional subsets of human T cells by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Early penetration of the blood-brain-barrier by HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Transcriptional but not translational regulation of HIV-1 by the tat gene product.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The accuracy of reverse transcriptase from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Induction of expression of HIV in latently or chronically infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Extensive variation of human immunodeficiency virus type-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The 3'-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukin-2 receptor and the ATP-binding site of the protein kinase family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Epitopes of the CD4 antigen and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Myelodysplasia in the acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in hum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A second post-transcriptional trans-activator gene required for HTLV-III replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Hematologic abnormalities in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characterization of long terminal repeat sequences of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

The HIV 'A' (sor) gene product is essential for virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A novel gene of HIV-1, vpu, and its 16-kilodalton product

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-infected cells are killed by rCD4-ricin A chain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus long terminal repeat responds to T-cell activation signals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Activation of human immunodeficiency virus type 1 by DNA damage in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

1 reference

7 January 2021

Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Nucleotide sequence of the AIDS virus, LAV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-specific cytotoxic T lymphocytes in seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Variable and conserved neutralization antigens of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Neutralizing antibodies and the course of HIV-induced disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Human immunodeficiency virus: the eighth gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Expression and characterization of the trans-activator of HTLV-III/LAV virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A naturally immunogenic virion-associated protein specific for HIV-2 and SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960665-3

7 January 2021

10.1016/S0065-2776(08)60665-3

Identifiers

DOI

0 references

PubMed ID

2573256

1 reference

PubMed ID

2573256